HymonBio’s Products Once Again Debuts Overseas at 2023 MEDICA!


HymonBio’s Products Once Again Debuts Overseas at 2023 MEDICA!

China’s “Smart” Manufacturing

From November 13th to 16th, the world-renowned comprehensive medical exhibition MEDICA 2023 will be held in Düsseldorf, Germany. There, HymonBio will share with you innovative molecular detection reagent products.

Weixin Image_20231027161648


Innovating products and contributing Chinese strength to the global healthcare industry

Weixin Image_20231027161652

At present, 59 products have obtained EU CE certification, including cancer screening tests and pathogen molecular detection. At this exhibition, HymonBio will showcase innovative technologies and products to global customers.

Weixin Image_20231027161654

We will continuously develop and optimize innovative products to meet the needs of clinical molecular diagnosis. HymonBio’s rapid and highly efficient “one-step method” has been acknowledged by the US FDA and cited by a former FDA commission, contributing to China’s efforts in global pathogen detection.


Win-win cooperation and joint development

HymonBio has continuously expanded its product line and formed a comprehensive product line layout of “IVD reagent + instrument platform”. In addition to molecular diagnostic reagents, HymonBio is equipped with a magnetic bead nucleic acid extraction method, achieving rapid nucleic acid extraction, methylation conversion and other operational processes, greatly improving automation level and detection speed. Through continuous technological innovation and platform exploration, HymonBio provides stronger market competitiveness for its partners to achieve win-win cooperation.

Post time: Oct-27-2023